EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Individualized homoeopathy versus placebo in essential hypertension: A double-blind randomized controlled trial

Subhranil Saha, AchintyaKumar Datta, Shubhamoy Ghosh, SeikhIntaj Hossain, Munmun Koley, Malay Mundle, Goutam Nag, Prasanta Rath

Indian Journal of Research in Homoeopathy · 2013

DOI: 10.4103/0974-7168.116629 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Indian Journal of Research in Homoeopathy, 2013. Verfasst von Subhranil Saha und 7 weiteren Autor:innen. Die Arbeit wurde bisher 10-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hypertension is the most common cardiovascular disorder posing a major public health challenge to the population. Homoeopathy, although widely used in hypertension, is assumed to have nothing but placebo effects and its specific clinical effects are frequently ascribed as implausible.

Aims

To evaluate whether individualized homoeopathy can produce any significant effect different from placebo in essential hypertension by comparing the lowering of blood pressure between groups. Settings and Design: A prospective, double-blind, randomized, placebo-controlled, parallel-arm clinical trial was conducted at the Outpatient Clinic of the Mahesh Bhattacharyya Homoeopathy Medical College and Hospital, West Bengal. Material and Methods: Out of 233 hypertensives assessed for eligibility, 150 were enrolled and randomized (verum/homoeopathy 70, control/placebo 80). A total of 18 dropped out and 132 were regular (verum 64, control 68). The outcome measures were assessed after three months and six months. Statistical Analysis: The intention-to-treat population was subjected to statistical analysis. Group differences were tested using the χ2 test and independent t test. Repeated measure (ANOVA) was performed to compare the data of two groups obtained longitudinally at baseline, three months and six months.

Results

The baseline data were not significantly different between the groups. After six months, mean Systolic Blood Pressure (SBP) reduction was 26.6 mm Hg (95% CI 21.5, 31.7) in the homoeopathy group and SBP increased by 3.6 mm Hg (95% CI -8.7, 1.5) in the placebo group. Similarly, the mean Diastolic Blood Pressure (SBP) in the homoeopathy group reduced by 11.8 mm Hg (95% CI 9.2, 14.4) and increased by 1.6 mm Hg (95% CI -3.6, 0.4) in the placebo group. Repeated measures ANOVA also showed significant difference (P=0.0001) between the groups. Natrum muriaticum, Calcarea carbonica, Sulphur, Thuja occidentalis, Nitric acid and Medorrhinum were frequently prescribed.

Conclusion

Individualized homoeopathy produced a significantly different hypotensive effect than placebo.

Zitieren

APA

Saha, S., Datta, A., Ghosh, S., Hossain, S., Koley, M., Mundle, M., Nag, G., & Rath, P. (2013). Individualized homoeopathy versus placebo in essential hypertension: A double-blind randomized controlled trial. Indian Journal of Research in Homoeopathy. https://doi.org/10.4103/0974-7168.116629

Vancouver

Saha S, Datta A, Ghosh S, Hossain S, Koley M, Mundle M, et al. Individualized homoeopathy versus placebo in essential hypertension: A double-blind randomized controlled trial. Indian Journal of Research in Homoeopathy. 2013. doi:10.4103/0974-7168.116629

BibTeX
@article{Saha2013,
  author = {Saha, Subhranil and Datta, AchintyaKumar and Ghosh, Shubhamoy and Hossain, SeikhIntaj and Koley, Munmun and Mundle, Malay and Nag, Goutam and Rath, Prasanta},
  title = {Individualized homoeopathy versus placebo in essential hypertension: A double-blind randomized controlled trial},
  journal = {Indian Journal of Research in Homoeopathy},
  year = {2013},
  doi = {10.4103/0974-7168.116629}
}
Kostenlos starten →